Fresenius Kabi announced the immediate availability in the U.S. of its citrate-free adalimumab biosimilar IDACIO® (adalimumab-aacf) for use in the treatment of chronic autoimmune diseases for all...
Merck, known as MSD outside of the United States and Canada, announced the completion of the Prometheus Biosciences, Inc. acquisition. Prometheus is now a...
